Informações de Hologic Inc | Histórico, dados financeiros e desempenho de mercado

Mais detalhes de Hologic Inc Empresa

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

Informações da empresa

Código da empresaHOLX

Nome da EmpresaHologic Inc

Data de listagemMar 01, 1990

Fundado em1990

CEOMr. Stephen P. (Steve) Macmillan

Número de funcionários7063

Tipo de títulosOrdinary Share

Fim do ano fiscalMar 01

Endereço250 Campus Drive

CidadeMARLBOROUGH

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal01752

Telefone15082632900

Sitehttps://www.hologic.com/

Código da empresaHOLX

Data de listagemMar 01, 1990

Fundado em1990

Executivos da empresa

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.22M

+7.02%

Ms. Christiana Stamoulis

Independent Director

47.34K

+4.10%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

--

Mr. Essex D. Mitchell

Chief Operating Officer

9.93K

-34.65%

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

9.26K

+25.20%

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

7.06K

+15.71%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

6.09K

-1.12%

Ms. Nanaz Mohtashami

Independent Director

4.18K

+80.45%

Ms. Stacey D. Stewart

Independent Director

3.60K

+107.62%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.22M

+7.02%

Ms. Christiana Stamoulis

Independent Director

47.34K

+4.10%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

--

Mr. Essex D. Mitchell

Chief Operating Officer

9.93K

-34.65%

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

9.26K

+25.20%

Detalhamento da receita

Moeda: USDAtualizado em: dom, 6 de abr

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Disposables

663.70M

64.95%

Service

198.60M

19.44%

Capital equipment, components and software

154.20M

15.09%

Other

5.30M

0.52%

Por RegiãoUSD

Nome

Receita

Proporção

United States

757.90M

74.17%

Europe

148.90M

14.57%

Asia

59.80M

5.85%

Rest of World

55.20M

5.40%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Disposables

663.70M

64.95%

Service

198.60M

19.44%

Capital equipment, components and software

154.20M

15.09%

Other

5.30M

0.52%

Distribuição de ações

Atualizado em: sex, 16 de mai

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

11.99%

T. Rowe Price Investment Management, Inc.

7.94%

BlackRock Institutional Trust Company, N.A.

6.04%

State Street Global Advisors (US)

4.54%

Morgan Stanley Investment Management Ltd. (UK)

3.68%

Other

65.81%

Investidores

Proporção

The Vanguard Group, Inc.

11.99%

T. Rowe Price Investment Management, Inc.

7.94%

BlackRock Institutional Trust Company, N.A.

6.04%

State Street Global Advisors (US)

4.54%

Morgan Stanley Investment Management Ltd. (UK)

3.68%

Other

65.81%

Tipos de investidores

Investidores

Proporção

Investment Advisor

51.53%

Investment Advisor/Hedge Fund

39.81%

Hedge Fund

3.28%

Pension Fund

2.79%

Research Firm

2.57%

Bank and Trust

1.79%

Sovereign Wealth Fund

0.93%

Individual Investor

0.86%

Family Office

0.05%

Participação acionária institucional

Atualizado em: seg, 20 de jan

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q1

1598

236.91M

106.29%

-12.62M

2024Q4

1617

238.36M

106.18%

-10.05M

2024Q3

1583

240.17M

103.42%

-3.00M

2024Q2

1580

234.77M

100.61%

-6.88M

2024Q1

1595

233.34M

99.37%

-7.61M

2023Q4

1584

235.52M

98.14%

-14.13M

2023Q3

1574

242.15M

98.88%

-13.93M

2023Q2

1583

245.52M

99.77%

-12.39M

2023Q1

1582

247.98M

100.57%

-12.56M

2022Q4

1556

249.37M

101.43%

-12.38M

Ver Mais

Atividade dos acionistas

Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

26.79M

11.94%

-54.38K

-0.20%

Dec 31, 2024

T. Rowe Price Investment Management, Inc.

17.94M

7.99%

-4.20M

-18.97%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

13.65M

6.08%

-23.32K

-0.17%

Dec 31, 2024

State Street Global Advisors (US)

10.35M

4.61%

-60.64K

-0.58%

Dec 31, 2024

Morgan Stanley Investment Management Ltd. (UK)

8.44M

3.76%

-455.77K

-5.12%

Dec 31, 2024

Victory Capital Management Inc.

4.92M

2.19%

+24.36K

+0.50%

Dec 31, 2024

Geode Capital Management, L.L.C.

5.73M

2.55%

+144.84K

+2.59%

Dec 31, 2024

Mitsubishi UFJ Asset Management Co., Ltd.

4.40M

1.96%

+129.03K

+3.02%

Dec 31, 2024

Invesco Capital Management LLC

3.65M

1.63%

+569.91K

+18.49%

Dec 31, 2024

Columbia Threadneedle Investments (US)

3.38M

1.51%

-109.07K

-3.12%

Dec 31, 2024

Ver Mais

ETFs Relacionados

Atualizado em: sex, 6 de jun

Nome

Proporção

First Trust Nasdaq Lux Digi Health Solutions ETF

4.03%

LeaderShares AlphaFactor Tactical Focused ETF

3.25%

First Trust Indxx Medical Devices ETF

2.02%

Formidable ETF

1.96%

First Trust Health Care Alphadex Fund

1.84%

SPDR S&P Health Care Equipment ETF

1.82%

Invesco S&P 500 Equal Weight Health Care ETF

1.72%

iShares U.S. Medical Devices ETF

1.68%

ROBO Global Healthcare Technology & Innovation ETF

1.48%

John Hancock Fundamental All Cap Core ETF

1.45%

Ver Mais

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporção4.03%

LeaderShares AlphaFactor Tactical Focused ETF

Proporção3.25%

First Trust Indxx Medical Devices ETF

Proporção2.02%

Formidable ETF

Proporção1.96%

First Trust Health Care Alphadex Fund

Proporção1.84%

SPDR S&P Health Care Equipment ETF

Proporção1.82%

Invesco S&P 500 Equal Weight Health Care ETF

Proporção1.72%

iShares U.S. Medical Devices ETF

Proporção1.68%

ROBO Global Healthcare Technology & Innovation ETF

Proporção1.48%

John Hancock Fundamental All Cap Core ETF

Proporção1.45%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

Hologic Inc

65.180USD

Hologic Inc

65.180

Visão Geral

Empresa